Compare VOC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOC | GNTA |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7M | 34.0M |
| IPO Year | 2011 | 2021 |
| Metric | VOC | GNTA |
|---|---|---|
| Price | $2.84 | $1.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 59.2K | ★ 102.5K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | ★ 21.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $9,783,812.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.44 | $1.28 |
| 52 Week High | $5.12 | $10.00 |
| Indicator | VOC | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 39.00 |
| Support Level | $2.72 | $1.39 |
| Resistance Level | $2.96 | $1.70 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 71.43 | 38.10 |
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.